-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Werewolf Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q3 2024.
- Werewolf Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 43.7M shares, a 22.6% increase year-over-year.
- Werewolf Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 35.6M shares, a 23.5% increase from 2022.
- Werewolf Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 28.9M shares, a 56.4% increase from 2021.
- Werewolf Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 18.5M shares, a 1736% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)